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Abstract
Blocking Plasmodium falciparum transmission to mosquitoes has been designated a strate-
gic objective in the global agenda of malaria elimination. Transmission is ensured by
gametocyte-infected erythrocytes (GIE) that sequester in the bone marrow and at matura-
tion are released into peripheral blood from where they are taken up during a mosquito
blood meal. Release into the blood circulation is accompanied by an increase in GIE
deformability that allows them to pass through the spleen. Here, we used a microsphere
matrix to mimic splenic filtration and investigated the role of cAMP-signalling in regulating
GIE deformability. We demonstrated that mature GIE deformability is dependent on re-
duced cAMP-signalling and on increased phosphodiesterase expression in stage V game-
tocytes, and that parasite cAMP-dependent kinase activity contributes to the stiffness of
immature gametocytes. Importantly, pharmacological agents that raise cAMP levels in
transmissible stage V gametocytes render them less deformable and hence less likely to
circulate through the spleen. Therefore, phosphodiesterase inhibitors that raise cAMP lev-
els in P. falciparum infected erythrocytes, such as sildenafil, represent new candidate drugs
to block transmission of malaria parasites.
Author Summary
Malaria transmission is ensured by deformable mature gametocyte-infected erythrocytes
being taken up when a mosquito bites. Non-deformable immature gametocyte stages are
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sequestered in the bone marrow, as their lack of deformability would lead to their splenic
clearance. In the present study, we apply nano-filtration technology to mimic splenic re-
tention and demonstrate that deformability of transmissible mature stage V gametocytes
is regulated by parasite cyclic AMP-dependent kinase signalling. Importantly, when we
used drugs to raise cAMP levels we render transmissible mature gametocytes as stiff as
non-transmissible gametocytes. In contrast, when we inhibit the cAMP-dependent kinase
we render immature gametocytes more deformable. Thus, by two different approaches we
confirm that the drop in cAMP levels in mature gametocytes leads to an increase in their
deformability and hence more likely to circulate through the spleen. Our molecular obser-
vations have the potential to be translated into therapies for blocking malaria transmission
by demonstrating that raising cAMP levels with sildenafil also known as “Viagra” renders
mature gametocytes rigid. These findings provide the proof of principle that deformability
of circulating gametocytes is targetable by pharmacological agents and as such, it provides
a novel approach to prevent the spread of parasites. PDE inhibitors therefore represent
novel drug leads potentially capable of blocking transmission and improving the world-
wide fight to eliminate malaria from the human population.
Introduction
Recent renewed emphasis on the eradication of malaria has highlighted the need for novel in-
terventions to target the parasite during transmission from the human host to the mosquito.
Drug treatments to clear asexual blood stage parasites (that cause pathology) do not kill mature
gametocytes and therefore allow transmission to continue [1]. Transmission of malaria para-
sites relies on the sexual stages, termed gametocytes that circulate in the peripheral blood and
are taken up by Anophelesmosquitos during a blood meal. For Plasmodium falciparum, the
causative agent of the most severe form of human malaria, gametocyte maturation requires
about 10 days and is divided in five morphological stages [2]. During this period, immature
gametocyte-infected erythrocytes (GIE) sequester in internal organs such as bone marrow and
spleen [3–6]. Sequestration mechanisms of GIE are still unknown, although failure of imma-
ture GIE to adhere to endothelial cell lines in vitro [7], and absence on their surface of parasite
structures allowing cytoadhesion of asexual stages [8], suggest that GIE-host interactions are
unlikely to be mediated by cytoadhesion. Recent evidence rather suggests that GIE biomechan-
ical properties may play an important role in this process [9]. At maturation GIE are released
into the blood circulation, where they can persist for several days [10], thus increasing the like-
lihood of parasites being taken up during a mosquito blood meal and ensuring transmission.
This remarkable ability of mature GIE to circulate through the spleen is due to the important
deformability that they acquire during the transition between stages IV to V [9,11,12]. By con-
trast, immature GIE are particularly stiff, which likely contributes to their sequestration by me-
chanical retention [9]. Therefore, modulation of GIE mechanical properties plays a key role in
their microcirculatory behaviour and it has been proposed that interfering with mature GIE fil-
terability through spleen capillaries may represent a novel way to block parasite transmission
[4,9]. However, mechanisms mediating the switch in GIE deformability late in the maturation
process are still elusive. The disassembly of the microtubule subpellicular network subtending
the trilaminar membrane structure in the transition from stage IV to stage V gametocytes
probably contributes to this process [12–15]. The switch in deformability is also linked to the
de-association of the parasite-derived STEVOR proteins from the infected erythrocyte mem-
brane [9]. These processes must be tightly controlled and signalling likely plays a regulatory
PDE Inhibitors and Malaria Transmission
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role. In uninfected erythrocytes, changes in phosphorylation status, including phosphorylation
by cAMP-dependent kinase A (PKA), are known to regulate mechanical properties of the
erythrocyte membrane [16,17]. For instance, phosphorylation of band 4.1 by PKA may be cen-
tral to the regulation of erythrocyte cytoskeletal organization and membrane mechanical prop-
erties [18]. PKA phosphorylation of dematin has also been shown to modulate the association
between actin and spectrin in the erythrocyte cytoskeleton [19,20]. In infected erythrocytes,
PKA activity results from both the human and the parasite enzymes [21]. During the parasite’s
life cycle, plasmodial PKA activity is implicated in a wide variety of processes including P. ber-
ghei sporozoite motility and liver cell invasion [22], P. falciparum erythrocyte invasion by mer-
ozoites [23,24], or modulation of infected erythrocyte membrane permeability [25]. So far,
there is no evidence for a regulatory role for cAMP-signalling during sexual development.
However, adenylate cyclase alpha (PfACα) is highly expressed in gametocytes [26], and
PKA activity is reportedly higher in gametocyte-producing parasites compared to parasites de-
fective in gametocyte production [27], suggesting a potential role for cAMP-signalling in
sexual development.
Here, we have investigated the role of cAMP-signalling in modulating GIE mechanical
properties. Using both genetic and pharmacological manipulation of cAMP signalling in con-
junction with the microsphiltration method to assess the ability of GIE to circulate through
inter-endothelial splenic slits, we show that a decrease in cAMP levels increases mature GIE
deformability, and conversely, increasing cAMP levels increases GIE stiffness. These findings
provide the proof of principle that molecules targeting phosphodiesterases (PDE) represent a
novel drug class capable of blocking malaria transmission.
Results
PfPKA-mediated phosphorylation contributes to immature GIE stiffness
To investigate whether PKA activity modulates GIE mechanical properties, we assessed the fil-
terability of GIE using the microsphiltration method, which mimics the physical constraints
experienced by infected erythrocytes in the splenic microcirculation [28,29]. In this system, in-
creased retention rates correspond to decreased erythrocyte deformability and impaired filter-
ability. We treated stage III GIE with KT5720 and H89, two independent and widely used PKA
inhibitors that also block a few other kinases [30,31] and that have already been shown to in-
hibit PKA activity in P. falciparum [21,24,32]. Before incubation with these inhibitors, approxi-
mately 94% of stage III GIE and 30% of stage V GIE were retained on the microspheres (Fig 1A
and S1 Fig), confirming the retention rates previously observed [9]. Importantly, incubation
with H89 and KT5720 significantly decreased the retention rates of stage III GIE (P = 3.10e-6
and 6.10e-6 for H89 and KT5720, respectively; Fig 1A) consistent with PKA activity contribut-
ing to immature GIE stiffness, whereas incubation of stage V GIE with H89 did not alter their
retention rates (S1 Fig). By contrast, stage III GIE retention rates were not affected upon incu-
bation with compound 2, a highly selective inhibitor of apicomplexan cGMP-dependent pro-
tein kinase (PKG) [33], or with GGTI-298, an inhibitor of the cAMP-effector exchange protein
activated by cAMP (EPAC) [34]. Furthermore, GIE filterability was not affected upon incuba-
tion with PKI-m, a membrane permeable inhibitor of the human PKA (PKA) that is a poor in-
hibitor of parasite PKA (PfPKA) [32]. This suggests that immature GIE filterability is
modulated by PfPKA, and not by human erythrocyte PKA.
To confirm this notion, we measured retention rates of a transgenic parasite that exhibits
a down-regulation in PfPKA activity due to episomal overexpression of the regulatory
(PfPKA-R) subunit of PfPKA (pHL-pfpka-r) [25]. cAMP binding to PKA-R liberates the cata-
lytic subunit (PKA-C) from inactive R/C complexes and over-expression of PKA-R acts as
PDE Inhibitors and Malaria Transmission
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Fig 1. PfPKA-mediated phosphorylation contributes to immature GIE stiffness. A. Retention in microsphilters of stage III GIEs from the B10 clone pre-
incubated 30 min to 1 h at 37°C with 10 μMH89, 10 μMKT5720, 10 μMPKI-m, 10 μM compound 2, 10 μMGGTI-298 or 0,1% DMSO (Control). Error bars
denote the standard error of the mean. *** and **Highly significant differences in retention rates (*** P< 0.001; **P< 0.01); ns: non-significant
differences in retention rates compared to control; n: number of experiments. Outliers are shown as open circles.B. Retention in microsphilters of stages III
GIEs from the B10 clone and the pHL-pfpka-r clone cultivated with and without pyrimethamine for 15 generations. The pHL-pfpka-r clone was pre-incubated
15 min at 37°C with 100μM 8Br-cAMP. Error bars denote the standard error of the mean. ***Highly significant differences in retention rates (P< 0.001); ns:
non-significant differences in retention rates; n: number of experiments. Outliers are shown as open circles.C. Western-blot analysis of PfPKA-R expression
in stage III GIE from the B10 clone and the pHL-pfpka-r clone cultivated in presence (+ pyr) or absence (- pyr) of pyrimethamine. Immunoblots were probed
with rabbit polyclonal antibodies directed against PfPKA-R and with a mAb directed against PfHSP70 to normalize expression. Black star indicates the
expected size for PfPKA-R (50.8 kDa); Red star indicates PfPKA-R with post-translational modifications. The experiment has been performed seven times.
Error bars denote the standard error of the mean. *Significant differences in phosphorylation signal (*P< 0.05); ns: non-significant differences in
phosphorylation signal.D. Quantitation of signal intensities in panel C using Quantity One software (BioRad). Analysis shows a 1.6-fold increase in PfPKA-R
expression in the pHL-pfpka-r clone (+ pyr) compared to B10. Decrease of PfPKA-R expression in absence of pyrimethamine (- pyr) indicates a loss of
episomal expression of the PfPKA-R protein. E. Immunofluorescence analysis of stage III GIE from the B10 clone and the pHL-pfpka-r clone cultured for 15
generations in the presence (+ pyr) or absence (- pyr) of pyrimethamine. Infected erythrocytes were stained with anti-PfPKA-R antibodies followed by anti-
rabbit Alexa 594-conjugated IgG. Pictures were taken under identical exposure conditions. The bars represent 2 μm.
doi:10.1371/journal.ppat.1004815.g001
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a cAMP sink dampening complex dissociation, so decreasing PfPKA activity. Immunoblotting
and immunostaining of gametocytes with specific antibodies indicated that PfPKA-R expres-
sion was significantly increased in pHL-pfpka-r transgenic parasites (Fig 1C, 1D and 1E). We
note that two PfPKA-R specific bands are identified in gametocytes compared to a single band
in schizonts [35], indicating that the R subunit undergoes translational modification during
gametocytogenesis. Microsphiltration analysis of pHL-pfpka-r immature GIE showed a signifi-
cant decrease in retention rates, similar to that observed upon incubation of wild-type GIE
with H89 (P = 0, Fig 1B). To confirm that decreased retention rates were due to dampened
cAMP-signalling, we measured deformability of pHL-pfpka-r immature GIE following incuba-
tion with the cell permeable, phosphodiesterase resistant cAMP analogue, 8Br-cAMP; raising
cAMP levels restored retention rates to wild-type phenotype (Fig 1B).
Loss of episomally derived PfPKA-R over-expression in pHL-pfpka-r transgenic parasites
should result in a regain in PfPKA activity and restoration in the levels of retention associated
with endogenous PfPKA expression. To promote shedding of the episome-encoded R subunit,
the pHL-pfpka-r transgenic line was cultured for several generations without pyrimethamine
selection required to retain the episome, leading to a new line called pHL-pfpka-r-wt. Immuno-
blotting and immunostaining of stage III GIE with specific anti-PfPKA-R antibodies confirmed
that PfPKA-R expression in pHL-pfpka-r-wt had reverted to that of wild type levels, consistent
with loss of the episome harboring the pfpka-r expression cassette (Fig 1C, 1D and 1E). Reten-
tion rates of pHL-pfpka-r-wt immature GIE were similar to wild-type GIE, indicating that the
retention phenotype mediated by over-expressed PfR-induced down-regulation of PfPKA ac-
tivity had reverted (Fig 1B). These results indicate that PfPKA-mediated phosphorylation con-
tributes to immature GIE stiffness.
Phosphorylation events contribute to the switch in deformability
To further demonstrate the contribution of PfPKA to immature GIE stiffness we probed mem-
brane extracts of stage III and stage V GIE using a monoclonal antibody specific for canonical
phospho-PKA sites (RRXS/T) (Fig 2A and 2B). The intensity of phosphorylation was 2-fold
lower in stage V GIE compared to stage III, indicating that membrane components were less
phosphorylated by PKA in mature than in immature gametocytes. At least five proteins dis-
played a higher degree of PKA site phosphorylation in stage III compared to stage V, suggest-
ing that these PKA substrates are potentially involved in mediating the membrane rigidity
phenotype (Fig 2A and 2B). Reduced PKA phosphorylation at stage V indicates a drop in
cAMP levels accompanies the switch in deformability that occurs at the transition between im-
mature and mature stages. The degree of cAMP-mediated phosphorylation can be increased by
treatment with calyculin A, a serine/threonine phosphatase inhibitor (known to inhibit P. fal-
ciparum phosphatase-1-like activities [36,37]) that diminishes dephosphorylation of PKA sub-
strates. Incubation of stage V GIE with calyculin A increased phosphorylation intensity at
2-fold to levels observed in stage III (Fig 2A and 2B). Consistently, incubation of stage V GIE
with calyculin A markedly impaired their filterability by increasing the retention rates in mi-
crospheres up to 90% (P = 0.0038), whereas it did not significantly affect filterability of unin-
fected erythrocytes (P = 0.7; Fig 2C). To validate that increased retention rates triggered upon
incubation with calyculin A corresponded to a decrease in GIE deformability, we visualized the
shape of GIE as they flowed through the matrix by adding a paraformaldehyde-fixation step to
the microsphiltration experiment (Fig 2D and 2E). 30% of untreated GIE maintained their
original shape, whereas 70% displayed a twisted and deformed shape, likely reflecting their
ability to squeeze and slide between microspheres [9]. Upon incubation with calyculin A the
proportion of deformed GIE decreased from 70% to 40% (Fig 2D and 2E). To rule out any
PDE Inhibitors and Malaria Transmission
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Fig 2. Phosphorylation events contribute to the switch in deformability. A.Western-blot analysis of Phospho-PKA site (RRXS*/T*) expression in
uninfected red blood cells (uRBCs), MACS-purified stage III (stIII) and stage V (stV) GIE from the B10 clone treated (+Calyc) or not (-Calyc) with 50 nM
calyculin during 2h at 37°C. Analysis was performed on membrane extracts recovered by centrifugation after 1% Triton X100 treatment. Immunoblot was
probed with rabbit monoclonal antibody directed against phospho-PKA sites (RRX*S/*T) and with mouse mAb directed against Band 3 to normalize
expression. Red arrows show bands with more intense phosphorylation signal in stage III GIE than in stage V GIE. Green arrow show band with less intense
phosphorylation signal in stage III GIE than in stage V GIE. The experiment has been performed three times. Error bars denote the standard error of the
mean. ***Highly significant differences in phosphorylation signal (P< 0.001). B.Quantitation of signal intensities in panel D using Quantity One software
(BioRad). The strength of the phosphorylation signal in untreated uninfected red blood cells lysate was set to 1 and all other signals are relative to that.C.
Retention in microsphilters of stages V GIEs (light grey), or uninfected red blood cells (uRBCs, dark grey). GIEs were pre-incubated at 37°C for 2 h with 50
nM calyculin, or 0.5% DMSO (control). ***Highly significant differences in retention rates compared to control (P< 0.001); ns: non-significant differences in
retention rates compared to control; n: number of experiments. D. Graphical representation for the proportion of GIE showing a regular (light green), or
deformed (dark green) shape in a population of paraformaldehyde-fixed GIE, as they flow through the microsphilters after pre-incubation at 37°C 2 h with 50
nM calyculin, or 0.5% DMSO (control). E. Differential interference contrast images of paraformaldehyde-fixed GIE, as they flow through the microsphilters. A
majority of DMSO-treated GIE (left panel) are twisted and deformed, whereas inhibitor-treated GIE (right panel) keep a regular shape, unlike uninfected
erythrocytes (red star).
doi:10.1371/journal.ppat.1004815.g002
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cytotoxic effect of calyculin A on gametocytes that could un-specifically result in higher cell
rigidity, we measured parasite lactate dehydrogenase activity immediately and 72 h after caly-
culin A treatment and validated that gametocyte viability was not affected (Table 1). Manipu-
lating the phosphorylation status using calyculin A clearly affects GIE mechanical properties
and given the documented effect of calyculin A on PKA activity in other systems [37], it is con-
sistent with PfPKA activity in mediating gametocyte deformability.
GIE filterability is dependent on cAMP concentration
The above results suggest that changes in cellular cAMP levels influence GIE deformability via
PKA activation. We first measured cAMP concentrations in MACS-purified GIE at immature
and mature stages. Intracellular levels of cAMP decrease approximately five-fold in stage
V GIE compared to stage III GIE (P = 0.008; Fig 3A), while PfPKA-R levels are unaltered be-
tween immature and mature stages (Fig 3B). Thus, increased deformability of stage V GIE is
accompanied by reduced PKA activity due to a decrease in cAMP levels. This notion was un-
derscored by increasing cAMP levels via addition of 8Br-cAMP and measuring the filterability
of stage III compared to stage V gametocytes. Upon incubation with 8Br-cAMP, retention
rates of stage III GIE were not modified, whereas those of stage V GIE were proportionally aug-
mented with increasing concentrations of 8Br-cAMP. High concentrations of 8Br-cAMP did
not affect filterability of uninfected erythrocytes, indicating that 8Br-cAMP specifically affects
P. falciparummature GIE (Fig 3C). Analysis of Giemsa stained smears of stage V GIE upstream
and downstream of the microsphere matrix showed unaltered male:female ratios indicating
that both male and female gametocytes use cAMP to regulate infected cell deformability.
cAMP degradation by phosphodiesterases regulates GIE mechanical
properties
The drop in cAMP concentration in stage V GIE might be a result of either reduced cAMP syn-
thesis by adenylate cyclases, or increased degradation by phosphodiesterases (PDEs). In P. fal-
ciparum, four genes encode PDEs: PfPDEα (PF3D7_1209500.1), PfPDEβ (PF3D7_1321500.1),
PfPDEγ (PF3D7_1321600) and PfPDEδ (PF3D7_1470500) [38,39]. We performed real-time
RT-PCR to quantify mRNA levels for all PDEs in asexual blood-stages as well as in immature
and mature gametocytes. PfPDEα and PfPDEβ are mainly expressed in asexual blood-stages,
PfPDEγ is minimally expressed in all blood-stages, whereas PfPDEδ is highly expressed in stage
Table 1. Viability of 3D7 stage V GIE treated with different inhibitors.
Treatment Dose PreTreatment min pLDH (time 0) % Controls ±SD pLDH (after 72 h) % Controls±SD
Medium 100 100
Sildenaﬁl citrate 100 μM 30 117.95 ± 5.4 99.07 ± 7.5
H89 10 μM 30 94.44 ± 11.8 86.41 ± 7.1
GGTI298 10 μM 30 105.81 ± 12.1 94.89 ± 4.6
Zaprinast 65 μM 30 112.16 ± 15.7 83.72 ± 7.9
Calyculin A 50 nM 120 124.01 ± 10.5 84.91 ± 8.7
8Br-cGMP 150 μM 30 103.20 ± 28.8 86.97 ± 10.6
Forskolin 150 μM 30 94.83 ± 14.6 95.92 ± 25.1
3D7 Stage V GIE were treated with the inhibitors for the indicated times, then washed and their viability evaluated with the colorimetric pLDH assay either
immediately (time 0) or after 72 h incubation at 37°C, as described [56]. The data are expressed as percent of untreated controls and are the mean of two
experiments in quadruplicate.
doi:10.1371/journal.ppat.1004815.t001
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Fig 3. GIE filterability is dependent on cAMP concentration. A. cAMP concentration drops in mature GIE.
The total intracellular cAMP concentration was measured in stage III and V GIE using a competitive
immunoassay for the quantitative determination of cAMP. GIE were harvested by magnetic isolation and
aliquots of 6.106 cells were assayed in duplicate wells. The assay was carried out three times. Error bars
denote the standard error of the mean. **Highly significant difference compared to stage III GIE (P< 0.01).
B. Western-blot analysis of PKA-R expression in MACS-purified stage III and stage V GIE (5.10e6 parasites/
lane). Immunoblots were probed with rabbit polyclonal antibodies directed against PfPKA-R and with a mAb
directed against PfHSP70 to normalize expression. Quantity One (BioRad) analysis shows that PfPKA-R
levels were not significantly different between stage III and stage V. C. Retention rates in microsphilters of
stage III GIE (dark grey), stage V GIE (light grey) and uninfected red blood cells (uRBC, black) pre-incubated
15 min at 37°C with different concentrations of 8Br-cAMP. Error bars denote the standard error of the mean.
Outliers are shown as open circles. **Highly significant differences in retention rates compared to control
without 8Br-cAMP (P< 0.01); ns: non-significant differences in retention rates compared to control; n:
number of experiments.
doi:10.1371/journal.ppat.1004815.g003
PDE Inhibitors and Malaria Transmission
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V gametocytes (Fig 4A). Importantly, mRNA levels of PfPDEδ increase approximately two- to
three-fold in stage V compared to stage III gametocytes. These results are consistent with ex-
pression data available at PlasmoDB (http://www.plasmodb.org/), where PfPDEδ is annotated
as almost exclusively expressed in stage V gametocytes [40,41].
To determine whether PfPDEδ is involved in triggering the switch in deformability observed
in stage V GIE, we analysed retention rates for mature GIE from transgenic parasites in which
the PfPDEδ gene had been deleted [42]. We first measured cAMP concentration in MACS-
purified stage III and stage V GIE and found loss of PfPDEδ activity led to a two-fold increase
in cAMP levels in both immature and mature GIE (Fig 4B). Microsphiltration analysis of
Fig 4. cAMP degradation by phosphodiesterases regulates GIEmechanical properties. A.mRNA levels of four PDEs were determined by real time
RT-PCR in asexual blood-stages (asex), stage III GIE (st.III) and stage V GIE (st.V). Relative amounts of transcript were normalized to mRNA levels of the
PfHK (PF08_0085), Pfs48/45 (PF13_0247) and Pfs25 (PF10_0303) were used as markers of stage III and stage V GIE, respectively. Triplicate PCR reactions
were analysed for each sample.B. The total intracellular cAMP concentration was measured in stage III and V GIE from the 3D7 clone and the PfPDEδ-
mutant clone 4 using a competitive immunoassay for the quantitative determination of cAMP. GIE were harvested by magnetic isolation and aliquots of 6.106
cells were assayed in triplicate wells. The assay was carried out at least three times for each clone. C. Retention in microsphilters of stages V GIEs from the
3D7 clone and the PfPDEδ-mutant clone 4. Error bars denote the standard error of the mean. Outliers are shown as open circles. n: number of experiments.
doi:10.1371/journal.ppat.1004815.g004
PDE Inhibitors and Malaria Transmission
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mature GIE from the PfPDEδ-mutant line showed a significant increase in retention rates
(Fig 4C), indicating that this phosphodiesterase participates in regulating cAMP levels in ma-
ture gametocytes and hence GIE deformability.
Pharmacological perturbation of cellular cAMP levels impairs mature
GIE filterability
As an alternative way to investigate the effects of raising cAMP levels in GIE, we used pharma-
cological agents such as forskolin, an activator of mammalian adenylate cyclase, and zaprinast,
an inhibitor of PDEs. Although zaprinast is well known as an inhibitor of mammalian PDE5, a
cGMP phosphodiesterase, it is known to increase cAMP levels in human erythrocytes [43], and
can inhibit both cAMP- and cGMP-PDE activities in P. falciparum (Table 2) [39]. To validate
the effect of these molecules on intracellular levels of cAMP, we measured its concentration in
MACS-purified stage V GIE and found a two-fold increase in cAMP levels in cells treated with
either compound (P = 0.029 and 0.024 for forskolin and zaprinast, respectively; Fig 5A). Im-
portantly, incubation of stage V GIE with either forskolin or zaprinast markedly increased
microsphere retention rates by up to 82% (P = 0) and 86% (P = 0.0002), respectively. Both re-
agents showed no significant effect on filterability of uninfected erythrocytes (P = 0.49 and 0.20
for forskolin and zaprinast, respectively; Fig 5B). Upon incubation with forskolin or zaprinast,
the proportion of paraformaldehyde-fixed mature GIE that exhibit a deformed shape as they
flowed through the matrix was decreased to 45% and 31%, respectively, compared to 70% of
untreated cells (Fig 5C). The ensemble indicates that pharmacological agents that raise levels
of cAMP affect mature GIE deformability impairing their ability to pass through an in vitro
model for splenic filtration.
PDEs have been well studied as potential drug targets in relation to numerous diseases. For
example, the PDE5 and PDE6 inhibitor sildenafil (Viagra) is a widely used to treat erectile
dysfunction. As a first step to address the potential of sildenafil to impair the circulation of
P. falciparummature gametocytes in humans and thereby block malaria transmission to mos-
quitoes, we measured the cAMP concentration in MACS-purified stage V GIE following incu-
bation with sildenafil. We found that 100 μM sildenafil triggered an approximately four-fold
increase of intracellular levels of cAMP, leading to levels similar to those of immature GIE
(P = 0.0068; Fig 6A). An increase in cGMP levels was also measured following sildenafil treat-
ment (S2 Fig), consistent with our observations that both zaprinast and sildenafil can inhibit
both cAMP and cGMP hydrolytic activities (Table 1). Upon incubation with different concen-
trations of sildenafil from 10 nM to 100 μM, retention rates of stage V GIE increased in
Table 2. The effect of PDE inhibitors on particulate fractions isolated from P. falciparum parasites.
Target PDE class in humans Pf cAMP-PDE Pf cGMP-PDE Tb PDE1 Bovine PDE Human PDE
IBMX Non-selective > 200 > 200 > 1000 1.89 ± 4.38 3.95*
Rolipram PDE 4 speciﬁc (cAMP-speciﬁc) > 200 > 200 280 > 200 2
Zaprinast PDE 5 and 6 (cGMP-speciﬁc) 12.26 ± 1.23 3.03 ± 1.25 > 100 25.21 ± 1.71 0.5
Sildenaﬁl PDE 5 speciﬁc (cGMP-speciﬁc) 51.08 ± 1.59 22.52 ± 1.76 1 6.81 ± 1.29 0.0039
IC50 values (the concentration of compound that gave 50% inhibition of native PDE activity) are mean ± SEM in μM and were calculated using the Prism
software package (GraphPad Software, Inc.). Percentage inhibition data were ﬁtted to a sigmoidal dose-response curve using non-linear regression.
Bovine control PDE column displays cAMP dependent activity. All TbPDE1 and most Human values obtained from Kunz, et al.[58].
*Value obtained from Tang, et al.[59].
>200, sufﬁcient inhibition was not observed for an IC50 calculation.
Tb: Trypanosama brucei.
doi:10.1371/journal.ppat.1004815.t002
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a dose-dependent manner and reached 92% retention at 100 μM (Fig 6D). At 100 μM the pro-
portion of paraformaldehyde-fixed GIE that exhibit a deformed shape as they flowed through
the matrix decreased to 29%, compared to 70% of untreated cells (Fig 6B and 6C). Importantly,
mature GIE exhibited greatly reduced filterability with more than 75% retention with 1 μM sil-
denafil (666.7 ng/ml), which approximately corresponds to the reported peak serum concen-
tration reached in humans after 60 min following 100 mg oral dose (Cmax 440 ng/ml) [44,45].
The filterability of uninfected erythrocytes was not significantly affected at these sildenafil con-
centrations indicating that it specifically affects infected erythrocytes (P = 0.7012; Fig 6D).
Discussion
A novel paradigm that recently emerged postulates that the dynamics of immature P. falcipa-
rum GIE sequestration in the extravascular spaces of bone marrow and release of mature forms
into peripheral circulation through bone marrow endothelial slits depends on an increase in
GIE deformability at the transition from immature to mature stages [6,9]. The ability of mature
Fig 5. Interfering with cAMP levels impairs mature GIE filterability. A. Stage V GIE were harvested by magnetic isolation and incubated at 37°C for 30
min with 150 μM forskolin, 65 μM zaprinast, or 0.1% DMSO (Control). The total intracellular cAMP concentration was measured on aliquots of 6.106 cells in
duplicate wells. The assay was carried out three times. Error bars denote the standard error of the mean. *Significant differences in retention rates compared
to control (P< 0.05). B. Retention in microsphilters of stages V GIEs (light grey), or uninfected red blood cells (uRBCs, dark grey). GIEs were pre-incubated
at 37°C for 30 min with 150 μM forskolin, 65 μM zaprinast or 0,1% DMSO (control). ***Highly significant differences in retention rates compared to control
(DMSO) (P< 0.001); ns: non-significant differences in retention rates compared to control. n: number of experiments. C.Graphical representation for the
proportion of GIE showing a regular (light green), or deformed (dark green) shape in a population of paraformaldehyde-fixed GIE, as they flow through the
microsphilters after pre-incubation at 37°C for 30 min with 150 μM forskolin, 65 μM zaprinast or 0.1% DMSO (control).
doi:10.1371/journal.ppat.1004815.g005
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Fig 6. Sildenafil impairs mature GIE filterability. A. Stage V GIE were harvested by magnetic isolation and
incubated at 37°C for 30 min with 100 μM sildenafil, or 0.1% DMSO (Control). The total intracellular cAMP
concentration was measured on aliquots of 6.106 cells in duplicate wells. The assay was carried out five
times. Error bars denote the standard error of the mean. **Highly significant differences in retention rates
compared to control (DMSO) (P< 0.01).B.Graphical representation for the proportion of GIE showing a
regular (light green), or deformed (dark green) shape in a population of paraformaldehyde-fixed GIE, as they
flow through the microsphilters after pre-incubation at 37°C for 30 min with 100μM sildenafil, or 0.1% DMSO
(Control).C. Differential interference contrast images of paraformaldehyde-fixed GIE, as they flow through
the microsphilters. D. Retention rates in microsphilters of stage V GIE (light grey) and uninfected red blood
cells (uRBC, dark grey) pre-incubated 30 min at 37°C with different concentrations of sildenafil. Error bars
denote the standard error of the mean. Outliers are shown as open circles. *** and **Highly significant
differences in retention rates compared to control (**P< 0.01; ***P< 0.001); ns: non-significant differences
in retention rates compared to control. n: number of experiments.
doi:10.1371/journal.ppat.1004815.g006
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P. falciparum GIE to circulate and pass through narrow blood capillaries and splenic slits de-
pends on the deformability of both the parasites and the infected erythrocytes. Here, we have
provided new mechanistic insight into the regulation of GIE deformability, and importantly,
by demonstrating that GIE deformability is altered by zaprinast and sildenafil treatments we
provide the proof of concept that PDE inhibitors could open new avenues towards the design
of malaria transmission-blocking drugs.
Stiffer immature gametocyte stages have high levels of cAMP, but become more deformable
upon inhibition of PfPKA either pharmacologically or by overexpression of the PfPKA regula-
tory subunit. Deformability was not affected upon incubation with GGTI-298, making unlikely
that cAMP regulates GIE stiffness via activation of PfEPAC [35]. So one mechanism by which
raising cAMP levels induce GIE stiffness is via activation of PfPKA and its possible substrates
could be parasite proteins involved in mediating the deformability of the parasite itself, a para-
site protein(s) that remodels the erythrocyte membrane, or a protein(s) of erythrocyte origin.
For instance, glideosome associated protein (GAP) 45 and myosin A, which are components of
the microtubule subpellicular network subtending the trilaminar membrane structure in im-
mature gametocytes, have been identified as PKA substrates in asexual stages [12,46]. In unin-
fected erythrocytes PKA-mediated phosphorylation of dematin and protein 4.1 decreases their
ability to promote spectrin binding to F-actin, therefore modulating mechanical properties of
the erythrocyte [18,20]. In GIE these proteins may be phosphorylated by PfPKA in immature
stages and may become dephosphorylated by parasite phosphatases in deformable stage V ga-
metocytes. The effect on deformability of the phosphatase inhibitor calyculin A is consistent
with dephosphorylation playing a role. The detection of five bands showing a decrease in PKA
site phosphorylation in mature stages suggests that more than one PKA substrate likely con-
tributes to regulation of GIE deformability. Besides proteins from the erythrocyte cytoskeleton,
parasite-encoded STEVOR proteins are also attractive candidates to be PfPKA substrates. They
have been shown to impact on the deformability of erythrocytes infected with sexual and asex-
ual P. falciparum parasites, and the switch in deformability during gametocyte maturation is
linked to a de-association of STEVOR proteins from the erythrocyte membrane in mature
stages [9,47]. Interestingly, three serine residues and one threonine residue conserved across
the entire STEVOR family are predicted to be PKA sites (cbs.dtu.dk/services/NetPhosK). Thus,
phosphorylation of STEVOR proteins and its impact on STEVOR subcellular localisation and/
or their interaction with erythrocyte cytoskeleton could be dependent on PKA-mediated phos-
phorylation and future studies will address this point. In addition, the mature parasite-infected
erythrocyte surface antigen (MESA) is also expressed in sexual stages and interacts with the
erythrocyte cytoskeleton, where it binds to protein 4.1 [48,49]. The presence of four classical
PKA phosphorylation sites in MESA suggests that this protein might also be a target of PKA-
mediated changes in GIE mechanical properties.
PfPKA-mediated phosphorylation of proteins associated with the erythrocyte cytoskeleton,
or parasite proteins located in the erythrocyte membrane implies that the parasite kinase might
be exported into the erythrocyte cytosol. PfPKA-R and PfPKA-C sequences do not have a rec-
ognizable PEXEL/HT motif and whether they are secreted remains hypothetical; however,
there are proteins that lack a clear secretion signature that make up the non-PEXEL exportome
[50]. Furthermore, in the absence of compelling secretion data for PfPKA-R and PfPKA-C, we
entertain the possibility that PfPKA effects on erythrocyte membrane deformability may be
mediated indirectly, through PfPKA-dependent phosphorylation of other, as yet to be identi-
fied, secreted parasite effectors.
We found that the overall GIE cAMP concentration drops at the transition between imma-
ture and mature gametocyte stages, concomitant with the switch in deformability necessary for
transmission. We established that raising cAMP levels in stage V GIE with forskolin, zaprinast
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or sildenafil rendered them stiff, like immature GIE. Zaprinast and sildenafil treatment of stage
V GIE clearly led to a rise in cAMP levels and sildenafil also induced a small increase in the
amount of cGMP (S2 Fig). Consistent with these observations, retention rates of stage V GIE
proportionally augmented with increasing concentrations of 8Br-cGMP (S2 Fig). However,
cGMP levels do not change between stage III and V gametocytes [42] and moreover, inhibition
of the cGMP-dependent protein kinase (PfPKG) with the specific inhibitor compound 2 did
not alter stage III GIE retention rates at a concentration 20-fold higher than required to inhibit
erythrocyte invasion by merozoites [33]. Nonetheless, cGMP could impact indirectly on GIE
deformability via crosstalk with cAMP signalling, as already reported for uninfected erythro-
cytes [43]. These observations validate the use of sildenafil to increase mature GIE stiffness.
Several PDE inhibitors have been developed and used as therapeutic agents, and PDE5 has
received considerable attention over the last 10 years, with three selective inhibitors now on the
market (sildenafil, vardenafil, and tadalafil) [45]. In humans sildenafil acts by inhibiting both
PDE5 and PDE6, and we found that in P. falciparum-infected erythrocytes this inhibitor clearly
led to a rise in cAMP levels. Consistently, it increased GIE retention in an in vitromodel for
splenic filtration, demonstrating that administration of PDE inhibitors could be a new way to
block parasite transmission to mosquitoes. Interestingly, previous studies with PfPDEδ-mutant
line pointed to an essential role for cGMP-signalling in P. falciparum gametogenesis and ooki-
nete formation in the mosquito vector [42,51]. This suggests that inhibition of plasmodial
PDEs with sildenafil or derived analogues has the potential to raise both cAMP and cGMP lev-
els resulting in a block in both gametocyte transmission via changes in GIE deformability and
on ookinete development in mosquitoes.
Our observations provide an opportunistic approach towards the discovery of new malaria
transmission-blocking drugs, by taking advantage of the wealth of clinical data available for sil-
denafil, which been approved by the Food and Drugs Administration and is widely used in hu-
mans with little side effects to treat erectile dysfunction. In opposition to the Ehrlich’s “magic
bullet” which consists of targeting pathways that are essential for parasites, but absent in hu-
mans, this strategy, referred to as “inverted silver bullet” [52], open new avenues towards the
design of novel interventions to halt the spread of malaria to humans.
Materials and Methods
Gametocyte culture and stage specific purification
The P. falciparum clonal lines B10 and 3D7 (clones of NF54), and the transgenic lines pHL-
pfpka-r, and PfPDEδ- clone 4 have been described elsewhere [25,42,53]. Parasites were cultivat-
ed in vitro under standard conditions using RPMI 1640 medium supplemented with 10% heat-
inactivated human serum and human erythrocytes at a 5% haematocrit [54]. Synchronous pro-
duction of highly specific gametocytes stages was achieved according to described protocol
[55]. For the isolation of gametocytes, culture medium was supplemented with 50mM (final
concentration) N-acetylglucosamine (GlcNAc) from day 0 onwards and medium replacement
was continued for 5 days to eliminate the asexual stages. Gametocyte preparations were en-
riched in different experiments by magnetic isolation using a MACS depletion column (Milte-
nyi Biotec) in conjunction with a magnetic separator.
Measurement of intracellular cAMP levels and cGMP levels
Tomeasure cAMP and cGMP levels, 6.106 GIE were purified by magnetic isolation and the cell
pellets were incubated with drugs at 37°C, centrifuged at 1,500 x g for 5 min and washed with
PBS. Sample diluent containing detergents to lyse the cells, inactivate endogenous phosphodiester-
ases and stabilize the cyclic nucleotides was added to the pellet for 10 min at room temperature, as
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described in the kits protocol (FluoProbes, powered by Interchim). To avoid eventual interference
with the assay stemming from haemoglobin contained in the red blood cell lysate, proteins were
precipitated with 5% trichloroacetic acid (TCA) for 10 min on ice, and the precipitate was re-
moved by centrifugation at 1,500 x g for 10 min. The supernatant was carefully removed and
transferred to a clean tube. TCA was removed by four successive extractions with water-saturated
Diethyl ether. The cyclic nucleotides content was measured after acetylation using a commercially
available cAMPHigh Sensitivity Chemiluminescent Assay Kit or cGMPHigh Sensitivity Chemi-
luminescent Assay Kit (FluoProbes, powered by Interchim), cyclic nucleotides content was ex-
pressed as picomoles of cAMP or cGMP per 4.107 cells.
Drug treatments
Synchronized cultures containing 1 to 5% GIE were incubated 15 min to 2 h at 37°C with 10
nM to 150 μM 8Br-cAMP (8-Bromide-cyclic adenosine-monophosphate), 100 to 150 μM for-
skolin, 65 μM zaprinast, 50 nM Calyculin A, 10 nM to 100 μM sildenafil citrate, 10 μM com-
pound 2 (4-[7-[(dimethylamino)methyl]-2-(4-fluorphenyl)imidazo[1,2-a]pyridin-3-yl]
pyrimidin-2-amine), 10 μMH89, 10 μMKT5720, 10 μM PKI-m (Protein Kinase Inhibitor
myristoylated), 10 μMGGTI (GeranylGeranylTransferase I) 298 trifluoroacetate salt hydrate.
None of the compounds reported above, except Compound 2, PKI-m and KT5720, affected
stage V GIE viability measured as parasite lactate dehydrogenase (pLDH) levels [56]. Stage V
GIE were treated with compounds at the highest dose, for the indicated times, washed to re-
move the compounds and assayed for pLDH activity both immediately and after 72 h incuba-
tion at 37°C.
All reagents were purchased from Sigma-Aldrich or Euromedex, except Compound 2 that
was provided by DB.
Microsphiltration
Calibrated metal microspheres (96.50% tin, 3.00% silver, and 0.50% copper; Industrie des
Poudres Sphériques) with 2 different size distributions (5- to 15-μm-diameter and 15- to 25-
μm-diameter) composed a matrix used to assay infected erythrocyte deformability under flow,
as described [28,29]. Suspensions of synchronized cultures containing 1% to 5% GIEs were per-
fused through the microsphere matrix at a flow rate of 60 mL/h using an electric pump (Syr-
amed _sp6000, Arcomed_ Ag), followed by a wash with 5 mL of complete medium. The
upstream and downstream samples were collected and smeared onto glass slides for staining
with Giemsa reagent, and parasitaemia was assayed by counting 2000 erythrocytes to deter-
mine parasite retention versus flow-through. Retention rates of uninfected erythrocytes were
monitored after labelling a subpopulation of erythrocytes with PKH67 (Sigma-Aldrich) ac-
cording to manufacturer’s instructions. The proportion of labeled erythrocytes in upstream
and downstream samples was determined by fluorescence microscopy using a Leica DM 5000
B at 100X magnification.
Determination of GIE shape during microsphiltration
To visualize GIE shape during their flowing through the matrix, 1 mL of PBS/4% paraformal-
dehyde was added after perfusion of the GIE-containing culture on the microsphere matrix.
After 5 min of incubation, fixed GIEs were separated from the microspheres by a 3-step decan-
tation procedure, and GIE morphology was observed on a glass slide by light microscopy using
a Leica DM 5000 B at 100X magnification. Microsphiltration experiments were performed in
triplicate and 100 cells were counted per experiment.
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PDE assays
PDE activity in native parasite fractions was measured using a modification of a previously
published method [57]. Briefly, parasites were frozen in liquid nitrogen and stored at -80°C
until use. Parasites were resuspended in 500 μl lysis buffer (20 mM hepes and 250 mM sucrose,
pH 7.0), subjected to 5 cycles of freeze-thaw in liquid nitrogen and pelleted at 100,000 g for 30
min. Particulate fractions were resuspended in lysis buffer containing EDTA-free protease in-
hibitors (Roche). PDE assays were carried out in triplicate wells of a 96-well plate in the pres-
ence of [3H]-labelled cGMP or cAMP (GE Healthcare) for 30 min at 37°C. Reactions were
terminated by boiling the plate for 1 min, followed by a 3 min centrifugation at 900 g. 1 unit of
alkaline phosphatase was added to each well and incubated for 30 min at 37°C. [3H]-labelled
guanosine was separated from the radiolabelled cAMP/cGMP substrate using ion exchange
(BioRad AG 1 x 8 resin). Supernatants containing the [3H]-labelled guanosine product were
added to scintillation fluid (Optiphase Supermix, Wallac). Scintillation was measured using a
Wallac 1450 Microbeta Liquid Scintillation Counter (Perkin Elmer) and PDE activity was ex-
pressed in pmol cAMP or cGMP/min/mg protein. Inhibition assays were carried out in the
presence of compounds dissolved in DMSO. PDE assays for specific activity and IC50 determi-
nation were carried out at a native lysate dilution that gave 30% cGMP/cAMP hydrolysis.
RNA isolation and transcript expression analysis by real-time RT-PCR
RNA was isolated from purified GIE or asexual stages using Trizol (Invitrogen) according
to the manufacturer’s instructions and treated with DNAse I (Roche). RNA was reverse-
transcribed using Superscript II that was primed with random hexanucleotides (Invitrogen).
Real-time PCR was performed using an ABI Prism 7900HT sequence detector (Applied Biosys-
tems). Relative quantification of cDNA was performed using 2ΔCt method (User Bulletin 2,
ABI, http://www.appliedbiosystems.com). Triplicate PCR reactions were analyzed for each
sample. Transmission-blocking antigen precursor Pfs48/45 (PF13_0247) and ookinete surface
antigen precursor Pfs25 (PF10_0303) were used as markers of stage III and stage V gameto-
cytes, respectively. Transcript abundance was compared using mean of ΔCt values calculated
using ubiquitin-conjugating enzyme (PF08_0085) transcript (HK gene) as endogenous normal-
izer. Gene-specific primers used to profile the expression of PDEα, PDEβ, PDEγ and PDEδ
were published in Wentzinger et al (2008) [39], and gene-specific primers used to profile the
expression of Pfs48/45, Pfs25 and HK were published in Joice et al (2013) [6].
Western-blotting analyses
GIE were purified by magnetic isolation and pelleted by centrifugation at 1800rpm. To prepare
membrane extracts, 1.107 GIE were resuspended in 100 μl of PBS1X/1%Triton X-100, freezed
at -80°C overnight and centrifugated at 16000 g for 5 min at 4°C. To prepare total extracts,
5.106 GIE were used. Pellets were denatured in protein loading buffer 5 min at 100°C and were
separated by 4–12% SDS-PAGE, transferred to PVDF membrane and blocked for 1 h in 5%
nonfat dry milk. Immunoblots were probed overnight with a purified rabbit antiserum against
PfPKA-R at 1:16, a rabbit mAb anti-phospho-PKA substrate (RRXS/T, 100G7E, Cell Signal-
ing) at 1/1000, a mouse mAb anti-HSP70 antibody at 1/1000, or a mouse mAb anti-Band3
antibody (Sigma) at 1/5000 followed by 1 hour with horseradish peroxidase-conjugated anti-
mouse or anti-rabbit IgG secondary antibodies (Promega) at 1:10 000. Detection step was per-
formed using the Pierce chemoluminescence system (Pierce) following the manufacturer’s
instructions. The levels of PfPKA-R or phospho-PKA were quantified by densitometry using
the Quantity One analysis software (BioRad). For each sample, we then calculated the ratio of
protein levels relative to loading control HSP70 or Band 3.
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Indirect immunofluorescence microscopy
GIE were air-dried on glass blood smears and methanol-fixed for 10 min at -20°C. After 1h
pre-incubation in PBS1X/2% BSA, slides were incubated overnight with a purified rabbit anti-
serum against PfPKA-R at 1/50 and with AlexaFluor 594-conjugated goat anti-rabbit affinity-
purified IgG (Molecular Probes) for 1 hour. Parasite nuclei were stained with Hoechst 33342
(diluted 1:20000, Life technologies). Samples were observed at 100X magnification using a
Leica DM 5000 B.
Statistical analysis
Statistical significance for differences in cAMP concentration and in protein levels was estab-
lished using student test and Wilcoxon Mann-Whitney rank sum test. Statistical significance
for differences in retention rates was established using Wilcoxon Mann-Whitney rank sum
test. Statistical significance for differences in proportion of GIE showing different shape was es-
tablished using a Chi-square test.
Supporting Information
S1 Fig. Stage V GIE deformability is not altered by H89. Retention in microsphilters of stages
V GIEs. GIEs were pre-incubated at 37°C 30 min with 10 μMH89 or 0,1% DMSO (Control).
Outliers are shown as open circles. ns: non-significant differences in retention rates compared
to control. n: number of experiments.
(TIF)
S2 Fig. GIE filterability is dependent on cGMP concentration. A. Stage V GIE were harvested
by magnetic isolation and incubated at 37°C 30 min with 100 μM sildenafil, or 0.1% DMSO
(Control). The total intracellular cGMP concentration was measured on aliquots of 6.106 cells
in duplicate wells. The assay was carried out two times. Error bars denote the standard error of
the mean. B. Retention rates in microsphilters of stage V GIE (light grey) and uninfected red
blood cells (uRBC, dark grey) pre-incubated 15 min at 37°C with different concentrations of
8Br-cGMP. The assay was carried out at least three times at each 8Br-cGMP concentration.
Error bars denote the standard error of the mean. Outliers are shown as open circles.
(TIF)
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